UNCY - Unicycive Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

UNCY is currently covered by 6 analysts with an average price target of $22.25. This is a potential upside of $18.9 (564.18%) from yesterday's end of day stock price of $3.35.

Unicycive Therapeutics's activity chart (see below) currently has 23 price targets and 61 ratings on display. The stock rating distribution of UNCY is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 16.99% of the time, taking 74.77 days on average.

Highest price target for UNCY is $50, Lowest price target is $13, average price target is $22.25.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 29-Sep-2026. First documented stock forecast 09-Aug-2021.

Currently out of the existing stock ratings of UNCY, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Oct-2025

$13

$9.65 (288.06%)

$15

1 months 23 days ago
(29-Sep-2026)

0/4 (0%)

$8.45 (185.71%)

Buy Since 17-Aug-2021

$15

$10.2 (212.50%)

$13

3 months 1 days ago
(20-Aug-2026)

2/8 (25%)

$9.55 (175.23%)

332

Buy Since 17-Aug-2021

$15

$11.65 (347.76%)

$13

3 months 1 days ago
(20-Aug-2026)

0/11 (0%)

$9.55 (175.23%)

Buy Since 30-Jun-2026

$20

$16.65 (497.01%)

$22

3 months 8 days ago
(13-Aug-2026)

0/2 (0%)

$14.6 (270.37%)

Buy Since 29-Dec-2025

$25

$21.65 (646.27%)

$37

3 months 8 days ago
(13-Aug-2026)

0/4 (0%)

$19.6 (362.96%)

Show more analysts

Please expand the browser size to see the chart

What is UNCY (Unicycive Therapeutics) average time for price targets to be met?

On average it took 75 days for the stock forecasts to be reached, with an average price target met ratio of 16.99%.

Which analyst most recently updated their price target on UNCY (Unicycive Therapeutics)?

Swayampakula Ramakanth

Which analyst has the most public recommendations on UNCY (Unicycive Therapeutics)?

Swayampakula Ramakanth has 8 price targets and 14 ratings on UNCY

Which analyst is the currently most bullish on UNCY (Unicycive Therapeutics)?

Elemer Piros with the highest potential upside of $55.87

Which analyst is the currently most reserved on UNCY (Unicycive Therapeutics)?

Robert Leboyer with the lowest potential downside of -$1.13
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?